The Lead Episode 59: Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials-The Lead Episode 59 Speaker Information

The Lead Episode 59 Speaker Information

Pdf Summary

The document discusses the use of direct oral anticoagulants for preventing strokes in patients with device-detected atrial fibrillation, presenting a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials. Hosted by Dr. Jason T. Jacobson, the authors include William F. McIntyre, Alexander P. Benz, Nina Becher, Jeffrey S. Healey, and others. This article is published in the journal Circulation. The contributors for the discussion are William H. Sauer and Christian Thomas Ruff from Brigham and Women's Hospital. The disclosures reveal various involvements of the contributors in research, consulting, and speaking engagements with organizations such as American College of Cardiology, Zoll Medical Corporation, Abbott, Phillips, Biotronik, Biosense Webster, Inc., and others. The study aims to provide insights into how direct oral anticoagulants can be effective in preventing strokes in patients with atrial fibrillation.

Keywords

Direct oral anticoagulants

Strokes prevention

Device-detected atrial fibrillation

NOAH-AFNET 6 trial

ARTESiA trial

Meta-analysis

Dr. Jason T. Jacobson

Circulation journal

William F. McIntyre

Jeffrey S. Healey